Pfizer Pulls Menopause Hormone Therapy Premarin From Canadian Market
Source: Benzinga ·
Pfizer Inc. (NYSE:PFE) will reportedly no longer sell its hormone replacement therapy Premarin in Canada following an internal review, ending Canadian availability of both its vaginal cream and three oral tablet strengths. Pfizer Canada confirmed to Reuters on Thursday that it wi
Read the full story at Benzinga
Shared from the GodsView world desk: live wires next to a globe of flights, ships, fires, and quakes.